AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirfemac 200mg Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Pirfenidone (200mg)

Overview Pirfemac 200mg Tablet

Nintedanib 200mg tablets are a prescription medication for idiopathic pulmonary fibrosis. This treatment diminishes lung inflammation and scarring, improving breathing capacity. Administer this medication with food, consistently at the same time daily for optimal results. Dosage frequency varies depending on individual needs; your physician will determine the appropriate regimen to manage your symptoms. Continue treatment as directed by your doctor. Common side effects include sleep disturbances, headaches, lightheadedness, indigestion, nausea, diarrhea, and sun sensitivity. To mitigate dizziness, refrain from driving or activities demanding concentration. Weight loss and other adverse reactions are possible; regular weight monitoring or consultation with your doctor is advised. Liver function tests may be conducted during treatment. Inform your doctor of any pre-existing liver or kidney conditions, and all other medications you're currently using, as interactions can affect efficacy. Due to increased sun sensitivity, protective clothing and sunscreen are recommended during sun exposure. Disclose pregnancy or breastfeeding to your physician before commencing treatment.

Uses of Pirfemac 200mg Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pirfemac 200mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the 200mg Pirfemac tablet whole; avoid chewing, crushing, or breaking it. It should be taken with a meal.

Common Side effects of Pirfemac 200mg Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pirfemac 200mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 200mg Pirfemac Tablet should be administered with a meal.

How Pirfemac 200mg Tablet works:

Nintedanib 200mg tablets are an antifibrotic agent. Their mechanism involves inhibiting a specific endogenous molecule implicated in fibrotic processes. This consequently lessens lung scarring and inflammation, improving respiratory function.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Pirfemac 200mg Tablet is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pirfemac 200mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Pirfemac 200mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a 200mg Pirfemac tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Pirfemac 200mg Tablets cautiously, as dose modification may be necessary. Individuals with severe kidney disease or undergoing dialysis should avoid Pirfemac 200mg Tablets. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Pirfemac 200mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Pirfemac 200mg tablets are contraindicated in those with severe hepatic dysfunction.

What if you forget to take Pirfemac 200mg Tablet :

NA

Facts to Know About Pirfemac 200mg Tablet

LabelValue
Chemical Category Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Actions Idiopathic pulmonary fibrosis (IPF)

FAQs on Pirfemac 200mg Tablet

Before and during treatment with Pirfemac 200mg Tablet, your doctor will monitor your liver function—monthly for the first six months, then every three months thereafter. Lung function will also be checked periodically to assess your response to the medication.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, your doctor's prescribed Pirfemac 200mg Tablet treatment should be started and consistently followed to help maintain your current lung capacity.
Pirfemac 200mg Tablet may cause common side effects such as sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other possible side effects include upper respiratory and bladder infections, weight loss, insomnia, dizziness, drowsiness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues like acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions such as itching, redness, dryness, and rash are possible, as are muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzymes may be detected in blood tests.
Pirfemac 200mg tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, impairing breathing. This medication helps alleviate these effects, improving breathing.
You and your doctor should determine if Pirfemac 200mg Tablet is the appropriate treatment for you. Your doctor will prescribe it only after a proper assessment. Continued use depends on your response and how well you tolerate the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Never discontinue Pirfemac 200mg Tablet without your doctor's advice; it helps slow disease progression.
Minimize sun exposure while using Pirfemac 200mg Tablets. Daily sunscreen application and covering exposed skin (arms, legs, and head) are recommended. Smoking should also be avoided, as it reduces Pirfemac's effectiveness.
Pulmonary fibrosis patients typically survive 2–3 years, although some live significantly longer. Shorter survival is associated with older age, smoking, and lower BMI. Further contributing factors include advanced disease severity (radiologically and functionally) and the occurrence of additional lung complications.
Pirfemac 200mg Tablet
124
MRP 151
17% off